Breaking News Instant updates and real-time market news.

2020-05-28 16:07:47 ZS Zscaler $75.37 / +0.83 (+1.11%) 16:07 05/28/20 05/28 16:07 05/28/20 16:07	Zscaler reports Q3 EPS 7c, consensus 2c Reports Q3 revenue $110.5M, consensus $106.3M.	28 May 28 May 15 Jun
ZS Zscaler $75.37 / +0.83 (+1.11%) 05/26/20 Cowen Zscaler price target raised to $80 from $70 at Cowen 05/26/20 Barclays Zscaler price target raised to $75 from $64 at Barclays 04/24/20 Zscaler cut to Hold at SunTrust on valuation 04/24/20 Truist Zscaler downgraded to Hold from Buy at SunTrust

2020-05-28 16:07:47

Zscaler

$75.37 / +0.83 (+1.11%)

16:07

05/28/20

05/28

16:07

05/28/20

16:07

Zscaler reports Q3 EPS 7c, consensus 2c

Reports Q3 revenue $110.5M, consensus $106.3M.

28
May
28
May
15
Jun

ZS Zscaler

$75.37 / +0.83 (+1.11%)

05/26/20 Cowen: Zscaler price target raised to $80 from $70 at Cowen

05/26/20 Barclays: Zscaler price target raised to $75 from $64 at Barclays

04/24/20: Zscaler cut to Hold at SunTrust on valuation

04/24/20 Truist: Zscaler downgraded to Hold from Buy at SunTrust

TODAY'S FREE FLY STORIES

Hot Stocks	BlackBerry CFO Steve Rai sells almost $430K in company shares » 16:39 01/21/21 01/21 16:39 01/21/21 16:39 BB BlackBerry $12.83 / +0.05 (+0.39%) BlackBerry CFO Steve Rai… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BB BlackBerry $12.83 / +0.05 (+0.39%) 01/19/21 BlackBerry rises 17.4% 01/15/21 BlackBerry rises 20.8% 01/15/21 BlackBerry rises 22.7% 12/18/20 BlackBerry falls -13.1% BB BlackBerry $12.83 / +0.05 (+0.39%) 12/18/20 TD Securities BlackBerry price target raised to $8.50 from $5.50 at TD Securities 12/15/20 RBC Capital BlackBerry price target raised to $7.50 from $5 at RBC Capital 12/15/20 RBC Capital BlackBerry price target raised to $7.50 from $5.00 at RBC Capital 12/01/20 TD Securities BlackBerry jump on AWS pact looks like overreaction, says TD Securities BB BlackBerry $12.83 / +0.05 (+0.39%) 12/17/20 BlackBerry reports Q3 adjusted EPS 2c, consensus (1c) 09/24/20 BlackBerry reports Q2 non-GAAP EPS 11c, consensus 2c BB BlackBerry $12.83 / +0.05 (+0.39%) 01/15/21 BlackBerry reports settlement with Facebook over patents, Bloomberg says BB BlackBerry $12.83 / +0.05 (+0.39%) 01/20/21 #SocialStocks: Facebook could be in focus under new administration 12/17/20 Fly Intel: After-Hours Movers 12/01/20 Fly Intel: Wall Street's top stories for Tuesday 12/01/20 Fly Intel: Wall Street's top stories at midday BB BlackBerry $12.83 / +0.05 (+0.39%) 01/20/21 Notable open interest changes for January 20th 01/15/21 Unusual call flow in option market yesterday 01/14/21 BlackBerry call volume above normal and directionally bullish 01/11/21 Unusually active option classes on open January 11th
Earnings	Metropolitan Bank reports Q4 EPS $1.39, consensus $1.16 » 16:38 01/21/21 01/21 16:38 01/21/21 16:38 MCB Metropolitan Bank $38.08 / -0.98 (-2.51%) Q4 provision for loan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings MCB Metropolitan Bank $38.08 / -0.98 (-2.51%) 08/07/20 Metropolitan Bank appoints Greg Sigrist as CFO 08/05/20 Metropolitan Bank names Dixiana Berrios COO MCB Metropolitan Bank $38.08 / -0.98 (-2.51%) 12/15/20 JPMorgan Metropolitan Bank price target raised to $50 from $36 at JPMorgan 07/22/20 Keefe Bruyette Metropolitan Bank price target raised to $40 from $32 at Keefe Bruyette MCB Metropolitan Bank $38.08 / -0.98 (-2.51%) 10/21/20 Metropolitan Bank reports Q3 EPS $1.27, consensus 97c 07/22/20 Metropolitan Bank reports Q2 EPS $1.29, two estimates 79c
Syndicate	Akero Therapeutics files to sell 99.25M shares of common stock for holders 16:37 01/21/21 01/21 16:37 01/21/21 16:37 AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/13/20 Akero announces presentation of additional BALANCED study data analysis 10/16/20 Akero Therapeutics receives EMA PRIME designation for efruxifermin in NASH 09/30/20 Akero Therapeutics completes enrollment of cirrhotic patients in NASH study 09/24/20 Akero Therapeutics greenlit to continue efruxifermin Phase 2b/3 trial in NASH AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/13/20 H.C. Wainwright Akero Therapeutics price target raised to $64 from $62 at H.C. Wainwright 10/16/20 H.C. Wainwright Akero's PRIME designation an 'important recognition,' says H.C. Wainwright 09/10/20 Morgan Stanley Akero Therapeutics initiated with an Overweight at Morgan Stanley 08/31/20 B. Riley FBR NGM released 'overwhelmingly positive' NASH update, says B. Riley FBR AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/12/20 Akero Therapeutics reports Q3 EPS (63c), consensus (65c) 08/12/20 Akero Therapeutics reports Q2 EPS (57c), consensus (62c) 08 Jul AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 09/30/20 Before the Move: Watch Novo Nordisk, Bristol into AASLD abstract publication
Syndicate	Akero Therapeutics files to sell 1.1M shares of common stock 16:36 01/21/21 01/21 16:36 01/21/21 16:36 AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/13/20 Akero announces presentation of additional BALANCED study data analysis 10/16/20 Akero Therapeutics receives EMA PRIME designation for efruxifermin in NASH 09/30/20 Akero Therapeutics completes enrollment of cirrhotic patients in NASH study 09/24/20 Akero Therapeutics greenlit to continue efruxifermin Phase 2b/3 trial in NASH AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/13/20 H.C. Wainwright Akero Therapeutics price target raised to $64 from $62 at H.C. Wainwright 10/16/20 H.C. Wainwright Akero's PRIME designation an 'important recognition,' says H.C. Wainwright 09/10/20 Morgan Stanley Akero Therapeutics initiated with an Overweight at Morgan Stanley 08/31/20 B. Riley FBR NGM released 'overwhelmingly positive' NASH update, says B. Riley FBR AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 11/12/20 Akero Therapeutics reports Q3 EPS (63c), consensus (65c) 08/12/20 Akero Therapeutics reports Q2 EPS (57c), consensus (62c) 08 Jul AKRO Akero Therapeutics $29.90 / -0.35 (-1.16%) 09/30/20 Before the Move: Watch Novo Nordisk, Bristol into AASLD abstract publication
Hot Stocks	CarGurus CEO Langley Steinert shifts to chairman role, Jason Trevisan succeeds » 16:35 01/21/21 01/21 16:35 01/21/21 16:35 CARG CarGurus $31.86 / -0.07 (-0.22%) CarGurus announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CARG CarGurus $31.86 / -0.07 (-0.22%) 12/10/20 CarGurus to acquire 51% stake in CarOffer for $275M 11/20/20 Ford to launch used vehicle platform Ford Blue Advantage 08/25/20 CarGurus announces Global Lending Services as lending partner CARG CarGurus $31.86 / -0.07 (-0.22%) 12/14/20 BTIG CarGurus price target raised to $34 from $28 at BTIG 12/11/20 DA Davidson CarGurus found 'compelling' asset in CarOffer, says DA Davidson 12/10/20 Benchmark CarGurus' deal for CarOffer increases Benchmark's 'optimistic view' 12/04/20 Jefferies CarGurus initiated with a Hold at Jefferies CARG CarGurus $31.86 / -0.07 (-0.22%) 11/05/20 CarGurus sees FY20 EPS $1.01-$1.03, consensus 69c 11/05/20 CarGurus sees Q4 EPS 26c-28c, consensus 9c 11/05/20 CarGurus reports Q3 EPS 37c, consensus 22c 08/06/20 CarGurus sees FY20 EPS 66c-69c, consensus 44c CARG CarGurus $31.86 / -0.07 (-0.22%) 11/05/20 Fly Intel: After-Hours Movers 08/17/20 Fly Insider: Red Rock, CarGurus among week's notable insider trades 07/28/20 Tesla downgrade, Shopify upgrade among today's top calls on Wall Street

Initiation	Fisker initiated with a Market Perform at Raymond James » 16:33 01/21/21 01/21 16:33 01/21/21 16:33 FSR Fisker $15.00 / +0.235 (+1.59%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events Options FSR Fisker $15.00 / +0.235 (+1.59%) 01/04/21 Magna to collaborate with Fisker on Advanced Driver Assistance System 12/17/20 Fisker jumps with paid Ocean SUV reservations topping 10,400 globally 12/17/20 Fisker, Magna enter definitive platform, manufacturing agreements 12/10/20 Fisker falls -7.4% FSR Fisker $15.00 / +0.235 (+1.59%) 01/04/21 Fly Intel: Top five analyst initiations 01/04/21 Vertical Group Fisker initiated with a Buy at Vertical Group 12/30/20 Cowen Fisker estimates reduced following company guidance, says Cowen 12/11/20 Fly Intel: Top five analyst initiations FSR Fisker $15.00 / +0.235 (+1.59%) 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday 11/25/20 Ford, Gap downgrades among today's top calls on Wall Street 11/25/20 Fly Intel: Pre-market Movers 02/11/21 Technology & Internet Virtual Conference FSR Fisker $15.00 / +0.235 (+1.59%) 11:25 Today Fisker call volume above normal and directionally bullish 12/31/20 Largest borrow rate increases among liquid names 12/23/20 Fisker call volume above normal and directionally bullish 12/22/20 Largest borrow rate increases among liquid names
Earnings	People's United reports Q4 operating EPS 35c, consensus 33c » 16:32 01/21/21 01/21 16:32 01/21/21 16:32 PBCT People's United $14.15 / -0.32 (-2.21%) "We are pleased with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options PBCT People's United $14.15 / -0.32 (-2.21%) 09/22/20 People's United to sell People's United Insurance Agency to AssuredPartners PBCT People's United $14.15 / -0.32 (-2.21%) 01/07/21 Jefferies People's United upgraded to Buy with $16 price target at Jefferies 01/07/21 Jefferies People's United upgraded to Buy from Hold at Jefferies 12/17/20 Seaport Global Seaport Global rolls out coverage of Regional and Community Banks with 4 Buys 12/17/20 Seaport Global People's United initiated with a Buy at Seaport Global PBCT People's United $14.15 / -0.32 (-2.21%) 14:41 Today Notable companies reporting after market close 10/22/20 People's United reports Q3 EPS 34c, consensus 29c 10/22/20 Notable companies reporting after market close 07/23/20 People's United reports Q2 operating EPS 24c, consensus 22c 17:00 Today People's United - PBCT PBCT People's United $14.15 / -0.32 (-2.21%) 07/24/20 Early notable gainers among liquid option names on July 24th
Initiation	Noah Holdings initiated with an Overweight at Morgan Stanley » 16:31 01/21/21 01/21 16:31 01/21/21 16:31 NOAH Noah Holdings $49.27 / +0.07 (+0.14%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 11/30/20 Noah Holdings announces $100M share repurchase program NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 16:22 Today Morgan Stanley Noah Holdings initiated with an Overweight at Morgan Stanley 01/07/21 JPMorgan Noah Holdings downgraded to Neutral from Overweight at JPMorgan 07/10/20 Citi Citi boosts Noah Holdings target, opens 'positive catalyst watch' 03/30/20 Citi Noah Holdings upgraded to Buy from Neutral at Citi NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 11/30/20 Fly Intel: After-Hours Movers NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 11/30/20 Noah Holdings options imply 10.3% move in share price post-earnings 08/24/20 Noah Holdings options imply 3.1% move in share price post-earnings
Earnings	BancFirst reports Q4 EPS $1.06, consensus 74c » 16:31 01/21/21 01/21 16:31 01/21/21 16:31 BANF BancFirst $62.90 / -1.37 (-2.13%) The provision for credit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Options BANF BancFirst $62.90 / -1.37 (-2.13%) 10/01/20 BancFirst to sell $20M in loans, $38M in deposits to AmeriState Bank 08/27/20 BancFirst raises dividend on common stock to 34c from 32c per share 08/03/20 BancFirst to replace Sunrun in S&P 600 at open on 8/3 07/28/20 BancFirst to replace Sunrun in S&P 600 at open on 8/3 BANF BancFirst $62.90 / -1.37 (-2.13%) 10/15/20 BancFirst reports Q3 EPS 63c, consensus 76c BANF BancFirst $62.90 / -1.37 (-2.13%) 07/22/20 Two new option listings on July 22nd
Hot Stocks	National Bank raises quarterly dividend 5% to 21c from 20c per share » 16:30 01/21/21 01/21 16:30 01/21/21 16:30 NBHC National Bank $35.49 / -0.52 (-1.44%) The dividend will be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NBHC National Bank $35.49 / -0.52 (-1.44%) 08/05/20 National Bank announces 20c quarterly dividend NBHC National Bank $35.49 / -0.52 (-1.44%) 11/20/20 Fly Intel: Top five analyst downgrades 11/20/20 DA Davidson National Bank downgraded to Neutral from Buy at DA Davidson 11/20/20 DA Davidson National Bank downgraded to Neutral from Buy at DA Davidson 04/23/20 Stephens National Bank downgraded to Equal Weight from Overweight at Stephens NBHC National Bank $35.49 / -0.52 (-1.44%) 16:12 Today National Bank reports Q4 EPS 87c, consensus 66c 10/20/20 National Bank reports Q3 EPS 90c, consensus 58c 01/22/21 National Bank - NBHC

Syndicate	Aurora Cannabis announces $125M bought deal financing » 16:30 01/21/21 01/21 16:30 01/21/21 16:30 ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) Aurora Cannabis announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/14/21 Aurora Cannabis announces Canadian retail sales deal with Great North 01/06/21 Aurora Cannabis rises 13.7% 01/06/21 Aurora Cannabis rises 13.8% 12/16/20 Aurora Cannabis provides business update, closing Aurora Sun facility ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/06/21 BMO Capital Federal cannabis reform in U.S. likely to take time, says BMO Capital 12/17/20 BMO Capital Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital 12/04/20 Alliance Global Partners Alliance Global sees low odds of MORE Act passing this congressional session 12/02/20 Alliance Global Partners Alliance Global Partners sees UN cannabis reclassification helping legalization ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 11/09/20 Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4 10/30/20 Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance 09/22/20 Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4 09/22/20 Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter 11 Nov ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/08/21 Deal to legalize marijuana in New Jersey suddenly collapses, NJ.com says 01/05/21 NY lawmakers file marijuana bill for 2021 session, Marijuana Moment says 12/30/20 Mexico on track to become largest legal cannabis market, WSJ reports 12/17/20 NJ lawmakers pass legal weed bill, now goes to Gov. Murphy, NJ.com reports ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 11:31 Today Rising High: An exclusive talk with emulsion provider SoRSE Technology 01/14/21 Rising High: An exclusive talk with cannabinoid market research firm BDSA 01/07/21 Rising High: WeedMD consolidates medical distribution activities 12/31/20 Rising High: Canopy Rivers sells Canapar stake, Stem closes Driven deal ACB Aurora Cannabis $11.17 / -0.39 (-3.37%) 01/13/21 Aurora Cannabis call volume above normal and directionally bullish 01/11/21 Aurora Cannabis call volume above normal and directionally bullish 11/30/20 Aurora Cannabis call buyer realizes 57% same-day gains 11/27/20 Largest borrow rate increases among liquid names
Options	Preliminary option volume of 38.9M today » 16:30 01/21/21 01/21 16:30 01/21/21 16:30 Preliminary option volume… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Initiation	Oppenheimer starts DermTech with Outperform, $53 target » 16:29 01/21/21 01/21 16:29 01/21/21 16:29 DMTK DermTech $42.55 / -1.37 (-3.12%) Oppenheimer analyst Kevin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options DMTK DermTech $42.55 / -1.37 (-3.12%) 01/14/21 DermTech announces PLA study results published 01/12/21 DermTech says genomic patch testing for melanoma recommended by NCCN 01/05/21 DermTech appoints Ray Akhavan as general counsel 12/29/20 DermTech gets positive medical coverage by Geisinger Health System DMTK DermTech $42.55 / -1.37 (-3.12%) 16:21 Today Oppenheimer DermTech initiated with an Outperform at Oppenheimer 01/20/21 Craig-Hallum DermTech price target raised to $49 from $23 at Craig-Hallum 01/12/21 Lake Street DermTech price target raised to $52 from $24 at Lake Street 12/14/20 Craig-Hallum Craig-Hallum bullish on DermTech, initiates with a Buy DMTK DermTech $42.55 / -1.37 (-3.12%) 11/10/20 DermTech reports Q3 EPS (50c), consensus (55c) 07 Jan DMTK DermTech $42.55 / -1.37 (-3.12%) 01/12/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: After-Hours Movers 12/30/20 Fly Intel: Wall Street's top stories for Wednesday DMTK DermTech $42.55 / -1.37 (-3.12%) 11/25/20 new option listings on November 25th
Hot Stocks	Davidson Kempner reports 8.46% passive stake in Playa Hotels & Resorts » 16:27 01/21/21 01/21 16:27 01/21/21 16:27 PLYA Playa Hotels & Resorts $5.80 / -0.105 (-1.78%) Davidson Kempner… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly PLYA Playa Hotels & Resorts $5.80 / -0.105 (-1.78%) 11/16/20 Hilton La Romana reopens following temporary closure 11/04/20 Playa Hotels & Resorts to sell the Dreams Puerto Aventuras for $34.5M 10/08/20 Playa Hotels & Resorts resumes normal operations at Yucatan resorts 09/14/20 Playa Hotels & Resorts announces final phase of post pandemic openings PLYA Playa Hotels & Resorts $5.80 / -0.105 (-1.78%) 01/11/21 Macquarie Playa Hotels & Resorts price target raised to $8 from $7 at Macquarie 12/15/20 Citi Playa Hotels & Resorts upgraded to Neutral from Sell at Citi 07/02/20 Citi Playa Hotels & Resorts price target raised to $3 from $1 at Citi 04/29/20 SunTrust Playa Hotels & Resorts downgraded to Hold from Buy at SunTrust PLYA Playa Hotels & Resorts $5.80 / -0.105 (-1.78%) 11/04/20 Playa Hotels & Resorts reports Q3 EPS (57c), consensus (45c) 07 Jan 19 Nov PLYA Playa Hotels & Resorts $5.80 / -0.105 (-1.78%) 01/06/21 Fly Intel: After-Hours Movers
General news	Treasury Market Summary » 16:25 01/21/21 01/21 16:25 01/21/21 16:25 Treasury Market Summary:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Hot Stocks	Adamis announces SYMJEPI, epinephrine injection products at Walgreens » 16:24 01/21/21 01/21 16:24 01/21/21 16:24 ADMP Adamis Pharmaceuticals $1.26 / -0.17 (-11.89%) , WBA Walgreens Boots Alliance $47.06 / -1.06 (-2.20%) Adamis Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ADMP WBA ADMP Adamis Pharmaceuticals $1.26 / -0.17 (-11.89%) 01/20/21 Adamis Pharmaceuticals submits Tempol IND application to FDA 12/01/20 Adamis Pharmaceuticals intends to address all deficiencies in ZIMHI CRL 11/16/20 Adamis plunges after Complete Response Letter from FDA for ZIMHI application 08/25/20 Adamis Pharmaceuticals provides update on Annual Meeting of Stockholders WBA Walgreens Boots Alliance $47.06 / -1.06 (-2.20%) 01/13/21 Walgreens expands financial services in pact with Synchrony, Mastercard 01/12/21 Walgreens Boots Alliance makes majority investment in iA 01/06/21 Walgreens Boots Alliance accelerates VillageMD investment 01/06/21 Walgreens expects to complete admin. of vaccine first doses in SNF by Jan. 25 ADMP WBA ADMP Adamis Pharmaceuticals $1.26 / -0.17 (-11.89%) 11/17/20 Adamis Pharmaceuticals cut to Hold at Maxim after Zimhi CRL from FDA 11/16/20 Maxim Adamis Pharmaceuticals downgraded to Hold from Buy at Maxim 05/13/20 Maxim Adamis Pharmaceuticals upgraded to Buy from Hold at Maxim 05/13/20 Maxim Adamis Pharmaceuticals upgraded to Buy from Hold at Maxim WBA Walgreens Boots Alliance $47.06 / -1.06 (-2.20%) 01/15/21 Baird Walgreens Boots Alliance price target raised to $64 from $55 at Baird 01/11/21 Fly Intel: Top five analyst upgrades 01/11/21 Baird Baird upgrades Walgreens Boots Alliance following Q1 results 01/11/21 Guggenheim Walgreens Boots Alliance upgraded to Buy from Neutral at Guggenheim WBA WBA Walgreens Boots Alliance $47.06 / -1.06 (-2.20%) 01/07/21 Walgreens Boots Alliance backs FY21 adjusted EPS view up low single digits 01/07/21 Walgreens Boots Alliance reports Q1 adjusted EPS $1.22, consensus $1.03 01/06/21 Notable companies reporting before tomorrow's open 01/06/21 Notable companies reporting before tomorrow's open 18 Sep WBA WBA Walgreens Boots Alliance $47.06 / -1.06 (-2.20%) 12/20/20 CDC panel says frontline workers, people over 74 should be next, NYTimes reports 11/01/20 CVS, Walgreens among pharmacies set to give COVID vaccines, Bloomberg says 10/23/20 HHS says thousands of facilities opt into CVS, Walgreens vaccine deal, CNBC says 10/16/20 White House in vaccine administration deal with CVS, Walgreens, Politico reports WBA WBA Walgreens Boots Alliance $47.06 / -1.06 (-2.20%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Fly Intel: Wall Street's top stories for Thursday 01/07/21 Fly Intel: Wall Street's top stories at midday 01/07/21 Fly Intel: Pre-market Movers 14:00 Today Healthcare 01/22/21 Mapping Your Corporate Social Responsibility 01/28/21 Walgreens Boots Alliance Inc ADMP WBA ADMP Adamis Pharmaceuticals $1.26 / -0.17 (-11.89%) 08/28/20 Largest borrow rate increases among liquid names 08/26/20 Largest borrow rate increases among liquid names 08/14/20 Largest borrow rate increases among liquid names 07/30/20 Unusual call flow in option market yesterday WBA Walgreens Boots Alliance $47.06 / -1.06 (-2.20%) 01/11/21 Early notable gainers among liquid option names on January 11th 12/31/20 Walgreen Boots call volume above normal and directionally bullish 12/07/20 Unusually active option classes on open December 7th 12/04/20 Unusually active option classes on open December 4th
Initiation	Noah Holdings initiated with an Overweight at Morgan Stanley » 16:22 01/21/21 01/21 16:22 01/21/21 16:22 NOAH Noah Holdings $49.27 / +0.07 (+0.14%) Morgan Stanley initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 11/30/20 Noah Holdings announces $100M share repurchase program NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 01/07/21 JPMorgan Noah Holdings downgraded to Neutral from Overweight at JPMorgan 07/10/20 Citi Citi boosts Noah Holdings target, opens 'positive catalyst watch' 03/30/20 Citi Noah Holdings upgraded to Buy from Neutral at Citi 02/11/20 Citi Citi downgrades Noah Holdings to Neutral on coronavirus vulnerability NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 11/30/20 Fly Intel: After-Hours Movers NOAH Noah Holdings $49.27 / +0.07 (+0.14%) 11/30/20 Noah Holdings options imply 10.3% move in share price post-earnings 08/24/20 Noah Holdings options imply 3.1% move in share price post-earnings
Initiation	DermTech initiated with an Outperform at Oppenheimer » 16:21 01/21/21 01/21 16:21 01/21/21 16:21 DMTK DermTech $42.55 / -1.37 (-3.12%) Oppenheimer initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options DMTK DermTech $42.55 / -1.37 (-3.12%) 01/14/21 DermTech announces PLA study results published 01/12/21 DermTech says genomic patch testing for melanoma recommended by NCCN 01/05/21 DermTech appoints Ray Akhavan as general counsel 12/29/20 DermTech gets positive medical coverage by Geisinger Health System DMTK DermTech $42.55 / -1.37 (-3.12%) 01/20/21 Craig-Hallum DermTech price target raised to $49 from $23 at Craig-Hallum 01/12/21 Lake Street DermTech price target raised to $52 from $24 at Lake Street 12/14/20 Craig-Hallum Craig-Hallum bullish on DermTech, initiates with a Buy 12/14/20 Craig-Hallum DermTech initiated with a Buy at Craig-Hallum DMTK DermTech $42.55 / -1.37 (-3.12%) 11/10/20 DermTech reports Q3 EPS (50c), consensus (55c) 07 Jan DMTK DermTech $42.55 / -1.37 (-3.12%) 01/12/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: After-Hours Movers 12/30/20 Fly Intel: Wall Street's top stories for Wednesday DMTK DermTech $42.55 / -1.37 (-3.12%) 11/25/20 new option listings on November 25th
Options	Closing CBOE SPX and VIX Index summary for January 21st » 16:20 01/21/21 01/21 16:20 01/21/21 16:20 VIX Volatility Index S&P 500 Options $0.00 / + (+0.00%) The CBOE Volatility Index… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Options VIX Volatility Index S&P 500 Options $0.00 / + (+0.00%) 09:18 Today Overnight activity included 803 trades in SPX and 14 trades in VIX 01/20/21 Closing CBOE SPX and VIX Index summary for January 20th 01/20/21 Overnight activity included 911 trades in SPX and 20 trades in VIX 01/19/21 Closing CBOE SPX and VIX Index summary for January 19th
Initiation	Taylor Morrison initiated with a Neutral at Janney Montgomery Scott » 16:20 01/21/21 01/21 16:20 01/21/21 16:20 TMHC Taylor Morrison / + Janney Montgomery Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events TMHC Taylor Morrison / + 12/08/20 Taylor Morrison renews $100M stock repurchase program 09/03/20 Taylor Morrison reports August net sales orders up 74% year-over-year 08/30/20 Fly Intel: Top five weekend stock stories TMHC Taylor Morrison / + 01/08/21 RBC Capital Taylor Morrison downgraded to Sector Perform from Outperform at RBC Capital 12/18/20 Fly Intel: Top five analyst upgrades 12/18/20 Barclays Taylor Morrison upgraded to Overweight from Equal Weight at Barclays 10/26/20 Zelman Taylor Morrison downgraded to Hold from Buy at Zelman TMHC Taylor Morrison / + 10/28/20 Taylor Morrison reports Q3 EPS 87c, consensus 61c 07/30/20 Taylor Morrison reports Q2 EPS 50c, consensus 52c TMHC Taylor Morrison / + 08/29/20 Toll Brothers, Taylor Morrison could benefit from housing demand, Barron's says 02/17/21 Taylor Morrison

Initiation	TRI Pointe initiated with a Buy at Janney Montgomery Scott » 16:19 01/21/21 01/21 16:19 01/21/21 16:19 TPH TRI Pointe / + Janney Montgomery Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events TPH TRI Pointe / + 01/19/21 TRI Pointe consolidates six regional brands under Tri Pinte Homes 01/05/21 TRI Pointe to change corporate name to 'Tri Pointe Homes,' effective January 15 11/11/20 TRI Pointe announces $250M share repurchase program 10/22/20 TRI Pointe raises 2020 home deliveries view to 4,900-5,0000 from 4,400-4,700 TPH TRI Pointe / + 01/08/21 RBC Capital TRI Pointe downgraded to Sector Perform from Outperform at RBC Capital 10/26/20 Zelman TRI Pointe downgraded to Hold from Buy at Zelman 10/23/20 B. Riley Securities TRI Pointe upgraded to Buy with $27 price target at B. Riley 10/23/20 B. Riley Securities TRI Pointe upgraded to Buy from Neutral at B. Riley Securities TPH TRI Pointe / + 10/22/20 TRI Pointe reports Q3 EPS 61c, consensus 43c 07/24/20 TRI Pointe reports Q2 adjusted EPS 51c, consensus 31c 02/18/21 TRI Pointe - TPH
Hot Stocks	Conformis, Sites Medical announce non-exclusive development and supply agreement » 16:19 01/21/21 01/21 16:19 01/21/21 16:19 CFMS Conformis $1.39 / +0.165 (+13.47%) Conformis and Sites… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Syndicate Events CFMS Conformis $1.39 / +0.165 (+13.47%) 12/17/20 Conformis announces U.S. commercial launch of new Cordera Match Hip System 09/29/20 Conformis announces 510(k) clearance for Cordera Hip System 08/20/20 Conformis achieves second milestone under development, license agreements 08/10/20 Conformis says study reports 90% patient sastifaction post knee replacements CFMS Conformis $1.39 / +0.165 (+13.47%) 11/04/20 Conformis reports Q3 EPS (9c), consensus (12c) 10/06/20 Conformis reports preliminary Q3 revenue $16.1M, consensus $13.02M 08/05/20 Conformis reports Q2 EPS (3c), consensus (10c) 24 Sep 03/03/21 Conformis - CFMS
Initiation	PulteGroup initiated with a Buy at Janney Montgomery Scott » 16:19 01/21/21 01/21 16:19 01/21/21 16:19 PHM PulteGroup $47.56 / +0.88 (+1.89%) Janney Montgomery Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PHM PulteGroup $47.56 / +0.88 (+1.89%) 12/03/20 PulteGroup increases quarterly dividend by 17% 10/22/20 PulteGroup reports Q3 net new orders up 36% to 8,202 homes 10/22/20 PulteGroup reports unit backlog up 29% to 14,962 homes 08/30/20 Fly Intel: Top five weekend stock stories PHM PulteGroup $47.56 / +0.88 (+1.89%) 01/05/21 BofA PulteGroup downgraded to Underperform from Neutral at BofA 12/18/20 Barclays PulteGroup upgraded to Overweight from Equal Weight at Barclays 12/08/20 UBS PulteGroup initiated with a Buy at UBS 11/19/20 Truist PulteGroup upgraded to Buy from Hold at Truist PHM PulteGroup $47.56 / +0.88 (+1.89%) 10/22/20 PulteGroup reports Q3 adjusted EPS $1.34, consensus $1.12 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open 07/23/20 PulteGroup reports Q2 adjusted EPS $1.15, consensus 87c PHM PulteGroup $47.56 / +0.88 (+1.89%) 08/29/20 Toll Brothers, Taylor Morrison could benefit from housing demand, Barron's says PHM PulteGroup $47.56 / +0.88 (+1.89%) 07/23/20 Fly Intel: After-Hours Movers 01/28/21 PulteGroup - PHM PHM PulteGroup $47.56 / +0.88 (+1.89%) 12/17/20 Early notable gainers among liquid option names on December 17th 11/04/20 Early notable gainers among liquid option names on November 4th 10/26/20 PulteGroup put volume heavy and directionally bearish 08/04/20 PulteGroup call volume above normal and directionally bullish
Hot Stocks	PPG says demand continues to improve in many of its end-use markets » 16:19 01/21/21 01/21 16:19 01/21/21 16:19 PPG PPG $143.94 / -0.635 (-0.44%) The company states:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PPG PPG $143.94 / -0.635 (-0.44%) 01/11/21 PPG appoints Bhaskar Ramachandran as CIO 01/11/21 PPG reaches definitive agreement to acquire Worwag 01/08/21 PPG to acquire VersaFlex Family of Companies 01/05/21 PPG, Tikkurila agree to revise takeover offer price PPG PPG $143.94 / -0.635 (-0.44%) 01/20/21 Citi Citi adds PPG to US Focus List, removes FMC 01/14/21 Berenberg PPG upgraded to Buy with $165 price target at Berenberg 01/14/21 Berenberg PPG upgraded to Buy from Hold at Berenberg 12/01/20 Deutsche Bank PPG price target raised to $165 from $155 at Deutsche Bank PPG PPG $143.94 / -0.635 (-0.44%) 16:18 Today PPG reports Q4 EPS $1.59, consensus $1.58 14:41 Today Notable companies reporting after market close 10/19/20 PPG sees Q4 adjusted EPS $1.50-$1.57, consensus $1.44 10/19/20 PPG reports Q3 adjusted EPS $1.93, consensus $1.92 PPG PPG $143.94 / -0.635 (-0.44%) 10/19/20 Fly Intel: After-Hours Movers 10/09/20 GE reinstatement at Goldman among today's top calls on Wall Street 01/22/21 PPG - PPG PPG PPG $143.94 / -0.635 (-0.44%) 10/19/20 PPG Industries options imply 4.4% move in share price post-earnings
Earnings	IBM reports Q4 Cloud & Cognitive Software revenue $6.8B, down 4.5% » 16:18 01/21/21 01/21 16:18 01/21/21 16:18 IBM IBM $131.80 / +1.72 (+1.32%) Reports Q4 Global… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IBM IBM $131.80 / +1.72 (+1.32%) 16:17 Today IBM sees FY21 revenue growing based on current forex rates 01/19/21 IBM, Atos expand strategic global alliance for digital transformation 01/14/21 IBM to acquire Taos, terms not disclosed 01/14/21 Vonage names Jay Bellissimo as COO IBM IBM $131.80 / +1.72 (+1.32%) 10/20/20 Morgan Stanley Morgan Stanley continues to view IBM as 'a 2022 stock' 10/20/20 Citi IBM is 'getting even more complex,' says Citi 10/20/20 BMO Capital IBM price target lowered to $138 from $140 at BMO Capital 10/09/20 Morgan Stanley IBM price target raised to $140 from $128 at Morgan Stanley IBM IBM $131.80 / +1.72 (+1.32%) 16:16 Today IBM reports Q4 adjusted EPS $2.07, consensus $1.79 14:41 Today Notable companies reporting after market close 10/19/20 IBM reports Q3 Cloud & Cognitive Software revenue $5.6B, up 7% 10/19/20 IBM reports Q3 adjusted EPS $2.58, consensus $2.58 IBM IBM $131.80 / +1.72 (+1.32%) 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports 01/06/21 IBM restructuring sales organization, WSJ reports 11/25/20 IBM to eliminate 10,000 positions in Europe ahead of unit sale, Bloomberg says 10/11/20 IBM split might not mean speedy recovery, WSJ says IBM IBM $131.80 / +1.72 (+1.32%) 12:29 Today Fly Intel: What to watch in IBM's earnings report 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 17:00 Today IBM - IBM IBM IBM $131.80 / +1.72 (+1.32%) 15:04 Today IBM options imply 6.3% move in share price post-earnings 01/05/21 Unusually active option classes on open January 5th 10/30/20 IBM call volume above normal and directionally bullish 10/19/20 IBM options imply 6.1% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

TCBI
Today at 17:00

Texas Capital - TCBI Conference Calls
IBM
Today at 17:00

IBM - IBM Conference Calls
INTC
Today at 17:00

Intel - INTC Conference Calls
FOR
Today at 17:00

Forestar Group - FOR Conference Calls
PBCT
Today at 17:00

People's United - PBCT Conference Calls
ASB
Today at 17:00

Associated Banc-Corp - ASB Conference Calls
COST
Today at 17:00

Costco Wholesale Corporation Firm Sponsored Meetings
SIVB
Today at 18:00

SVB Financial - SIVB Conference Calls
AUPH
Tomorrow at 00:00

PDUFA Date for Voclosporin Government Event
Tomorrow at 00:00

Western Institutional Investor Virtual Conference Conferences

Virtual Conference

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink $56.93 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum $66.43 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities $13.00-14.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright $7.50-8.00
Fri	No deals

View All Syndicate Announcements »

Zscaler reports Q3 EPS 7c, consensus 2c

TODAY'S FREE FLY STORIES

Get Full Fly Access